Items tagged with Advocacy
Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson (post with simple image)
Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.
Survivors Statement (post with simple image)
Presented in the Opening Ceremony of the 50th Union World Conference on Lung Health by survivor Nandita Venkatesan.
TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs (post with simple image)
Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.
TB Alliance responds to questions raised by activists in relation to pretomanid (post with simple image)
MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.
New TAG report: Funding for TB research climbed to new high in 2018 (post with simple image)
The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.
Stop TB Partnership launches the updated Global Plan to End TB 2018-2022 (post with simple image)
The updated Global Plan calls for 2.6 billion USD per year for vital research and development of new TB diagnostic tools, new drug regimens and a new vaccine, and 13 billion USD per year for TB care and prevention.
Stop TB Partnership launches the TB Stigma Assessment Tool (post with simple image)
The Tool aims to assess the extent to which and how TB stigma acts as a barrier to accessing services and to support the development of recommendations to address TB stigma so that quality TB services are available, accessible and acceptable to all.
Stop TB Partnership launches the Challenge Facility for Civil Society 2019 (post with simple image)
The largest-ever call for proposals for community and civil society for a TB response that is rights-based, gender-transformative, people-centered and accountable is announced.
Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia (post with simple image)
Activists urge Sanofi to do the same in other countries.
MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)
Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.
Page 82 of 82 · Total posts: 0←First 81 82